Barrett Ablation denied as duplicate or overlapping therapy by Humana?

Humana's specific coverage criteria for barrett ablation are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denies Barrett's Esophagus Ablation as Duplicate Therapy — and Why You Can Appeal

Humana's duplicate-therapy denial for Barrett's esophagus ablation typically arises when the plan determines that the requested ablative procedure — such as radiofrequency ablation or cryotherapy — duplicates a procedure recently performed or already scheduled. In practice, these denials sometimes reflect coding confusion, administrative error, or a misreading of the clinical record. They can also arise when a provider schedules staged ablation sessions and the plan treats a follow-up session as a repeat of the original. Because Barrett's ablation frequently requires multiple planned treatment sessions to achieve clearance of dysplastic tissue, a duplicate-therapy denial applied to a staged protocol is often clinically and factually incorrect.

## Your Federal Appeal Rights

Under ACA §2719, ACA-regulated plans must provide internal appeal rights and access to independent external review by an IRO not affiliated with Humana. ERISA §503 applies to self-funded employer plans. You have approximately four months from the denial date to request external review. If waiting for a standard timeline would jeopardize your health — for instance, if dysplasia is progressing — you may request expedited review.

## The Appeal Process

1. Request the complete denial explanation. Humana must identify what specific prior service it considers duplicated and the policy provision it applied. 2. File a Level 1 internal appeal within Humana's deadline. Include documentation that distinguishes the requested service from the prior one. 3. Escalate to Level 2 if Level 1 is denied, then proceed to external review if the denial is upheld. 4. At external review, the IRO will assess whether the services are genuinely duplicative or whether the clinical protocol requires staged treatment sessions.

## Documentation to Gather

• Diagnosis confirmation: Pathology reports and endoscopy records establishing Barrett's esophagus with the degree of dysplasia (if any).
• Prior-treatment history: Records of any prior ablation sessions with dates, procedural notes, and outcomes, showing what tissue was treated and what remains.
• Clinical severity: Current endoscopy and biopsy results showing the state of the esophageal lining after prior treatment and the clinical rationale for additional treatment.
• Prescriber medical-necessity letter: A letter from your gastroenterologist or esophageal specialist explaining why the requested session is a planned, clinically necessary component of the treatment protocol — not a duplication of prior work.

## Criteria-Mapping Strategy

Obtain Humana's published medical policy for Barrett's esophagus ablation and identify where it addresses staged or repeat procedures. Pair each policy requirement with the specific clinical documentation that shows the requested service is a distinct, planned component of an ongoing treatment protocol. Reference the relevant gastroenterology society guidelines (such as those from the American Society for Gastrointestinal Endoscopy or the American College of Gastroenterology) generically to show that multi-session protocols are recognized standard of care for this condition.